Propanc Biopharma PPCB 深 沪
等待开盘 08-27 09:30:00 美东时间
3.03
-0.340
-10.09%
华盛通- 最 高3.26
- 今 开3.14
- 成交量 36.51万股
- 最 低 3.00
- 昨 收 3.37
- 总市值 3821.38万
- 52周最高 3.26
- 市盈率 静 --
- 换手率 2.89%
- 52周最低 0.00
- 委 比 83.08%
- 总股本 1261.18万
- 历史最高 3.26
- 量 比 0.06
- 振 幅 7.72%
- 历史最低 0.00
- 每 手 1
- 风险率 2.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Propanc Biopharma Provides Shareholder Update
Propanc Biopharma, a biopharmaceutical company, announced it has completed an initial public offering and up-listed on Nasdaq, raising $4 million to advance its lead asset, PRP, into a Phase 1B clinical study in 2026. PRP, a mixture of pancreatic enzymes, targets various cancers and aims to reprogram cancer cells to die naturally. The company also expanded its management team and strengthened its financial position, with plans to pursue strategic...
08-25 11:30
Propanc Biopharma closes public offering, uplists to NASDAQ
Propanc Biopharma (NASDAQ:PPCB) on Tuesday said that it closed an underwritten public offering of 1,000,000 shares of its common stock, at $4.00 per share for gross proceeds of $4M. Shares began tradi...
08-20 01:04
What's Going On With Propanc Shares Monday?
Propanc Biopharma shares are trading higher Monday. The company recently priced a $4 million public offering and began trading on the Nasdaq Capital Market.
08-19 01:57
Why Is Propanc Biopharma Stock (PPCB) Up 150% Today?
Propanc Biopharma stock was up on Monday alongside an uplisting and public offe...
08-18 19:44
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Shares of Dayforce Inc (NYSE:DAY) rose sharply in pre-market trading. Bloomberg...
08-18 18:51
一周IPO观察：中慧生物/银诺医药大涨，双登股份招股，奥克斯过讯，Bullish美股上市，Gemini递表
港股IPO观察 截止2025年的第33周，港交所2家上市，1家招股，3家聆讯，8家递表。 当周上市（2家） 研发流感疫苗的生物医药公司 $中慧生物-B(02...
08-18 12:02
美股机会日报丨“恐怖数据”符合预期，交易员下调美联储降息预期；巴菲特Q2新建仓股飙升，联合健康盘前涨超10%
“恐怖数据”符合预期，交易员下调美联储降息预期；巴菲特Q2新建仓股盘前飙升，联合健康涨超10%，纽柯钢铁涨近5%；美俄首脑即将举行会晤>>
08-15 20:49
Propanc Biopharma prices $4M stock offering
Propanc Biopharma (OTCPK:PPCB) priced a public offering of 1M shares at $4 each, expecting $4M in gross proceeds to fund working capital and general purposes. In connection with the offering, the comp...
08-15 16:11
Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering
Propanc Biopharma, a biopharmaceutical company developing novel cancer treatments, announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at $4.00 per share, expected to yield approximately $4 million in gross proceeds. The company plans to use the proceeds for working capital and general business purposes. Propanc also granted the underwriter a 45-day option to purchase up to 150,000 additional shares. T...
08-15 03:00
Propanc Biopharma Appoints New Chief Financial Officer
Propanc Biopharma ( ($PPCB) ) has shared an announcement. On August 13, 2025, P...
08-14 05:29
